Gastrointestinal Cancer News

A restrictive opioid prescription protocol of 3 days or less after hospital discharge appeared feasible among a cohort of patients who underwent surgery at a large cancer center, according to study results published in JAMA Oncology.

Cancer drugs that received approval based on increased OS compared with other measures had the lowest median annual cost, according to a research letter published in JAMA Internal Medicine.

Individuals diagnosed with cancer during incarceration or within a year after release from prison have a higher risk for cancer mortality than those never incarcerated, according to a study from Yale Cancer Center.

Although decision aids helped inform older adults about potential benefits and risks associated with colorectal cancer screening, the tools did not significantly influence patient preference for screening, regardless of health.

A triple-therapy combination extended OS compared with historical data among certain patients with advanced HPV-positive cancers, according to one of the agent’s manufacturers.

Robotic liver resection for hepatocellular carcinoma yielded better perioperative tolerability and may be a safe and effective alternative to open liver resection, according to research published in JAMA Surgery.

Exact Sciences announced its support for recent policy changes that aim to increase access to noninvasive colorectal cancer screening tests and require Medicare and most insurers to pay for colonoscopy after a positive stool-based test.

The FDA announced several regulatory actions the past few weeks.

Pancreatic cancer is among the deadliest malignancies, and those who specialize in its treatment eagerly embrace any tools that may help extend patient survival.

Often regarded in oncology as a complementary diagnostic or early detection tool, liquid biopsy has moved into routine clinical use to help guide treatment decisions in the era of targeted, molecular-based therapies.